Introduction
HIV, like any epidemic, is above all a social event. Social sciences have been hampered in their contribution to understanding the epidemic by limited conceptualization linked to an overriding concern with individual risk behaviours and cognitive-based approaches to risk reduction and treatment adherence. Some research on HIV prevention, treatment and impact mitigation has begun to grapple with concepts of risk environment [1, 2] and structural intervention [3] , but these approaches are still not fully integrated.
Hope has for some time been recognized as an important factor in disease progression [4, 5] . We propose two ways in which the concept of hope can contribute to improving HIV prevention and HIV treatment. First, we offer hope as a framework for understanding the relationship between risk, behaviour and the wider social and economic environment. Hope can be seen as a pivotal concept linking individual behaviours to social and economic contexts; a measurable manifestation of the ways that social and economic structures function as risk regulators for the individual [6] . We suggest that hope, a positive expectation of the future, is linked to the capacity for behaviour change and is partly a product of the quality and characteristics of the wider risk environment. This conceptualization clarifies some of the uses of the terms 'vulnerability' and 'susceptibility' that have been used to describe the link between socioeconomic environments, individual risk propensities and HIV infection [2, 7, 8] . Appadurai [9] has explored similar ideas through the concept of aspiration. Looked at from this perspective, we may see the implications of how HIV prevention interventions may seek to create environmental conditions conducive to securing and sustaining hope as part of the wider efforts enabling risk reduction. treatment (ART) for HIV, and in particular the relationship between treatment access, delivery and security. Here hope provides a heuristic device for investigating the uneasy balance between overarching narratives of hope and promise generated by global discourses of ART scale-up, and local lived experiences of ART uncertainty in the context of fragile treatment delivery systems. Taken together, individual and group hope levels can be seen as a critical variable in securing capacity for HIV prevention and HIV treatment. We note that certain environmental conditions may puncture or limit hope, leading to a lack of investment in the future as realized through engagement in HIV prevention and HIV treatment. It is therefore at once necessary for HIV prevention interventions to create the structural conditions conducive to securing hope, and important that global discourses of HIV treatment promise do not offer merely an illusion of hope to individuals living and working with HIV/AIDS.
Hope, risk and HIV prevention
It is no longer realistic to consider the problem of 'risk' merely in relation to individual behaviours. Therefore: 'Continuing misunderstanding of the nature of the problem, based on wrong assumptions about the drivers of other people's sex lives, will result in a waste of resource on inappropriate policy recommendations and interventions. If this realisation continues to elude politicians who ultimately determine the direction of much ''prevention'' policy, the resulting morbidity, mortality and consequent long term social and economic -and even politicalcosts will continue to accrue' [10] .
Although it is established that health outcomes and health risk behaviours are unequally distributed in all societies [11, 12] , the relationship between health and poverty is not direct, being mediated through poorly understood pathways from social structure to individual health outcomes [13] . The theoretical and political challenge is to deploy insights about the ecology of risk pragmatically. This involves developing social and structural interventions for HIV prevention that are evaluated by the common criteria of impact, effectiveness and cost [14] . The building blocks for such a pragmatic engagement rest on two foundations: first, recognition of the links between individual risk behaviours and the environments in which these occur; second, clarity about the ways in which different environments permit differing degrees of hope for the future and thus longer or shorter decision horizons for individuals.
Hope is a fundamental and measurable concept for linking individual behaviour to the characteristics of the surrounding risk environment [15, 16] . The environment is perhaps best thought of as a risk regulator of individual behavioural decisions, imposing constraints and opportunities that shape behavioural risk factors [17] . We propose that the concept of hope is a missing piece of the jigsaw linking the individual to the environment. Whereas some environments permit hope for a future, thus enabling individuals to take a long-term perspective on their current behaviours, other environments have the opposite effect, resulting in harmful sequelae for individuals and in the case of an epidemic of communicable disease, for the wider society. As illustrated by Fig. 1 , we hypothesize that high-risk environments link with weak hope, and thus also, weak capacity for investment in the future, including through HIV prevention, whereas low-risk environments secure the presence of hope, and thus also stronger capacity for HIV prevention.
A growing body of research links aspects of the social environment to risk behaviour and health inequality [17, 18] . Important here is the embodiment of social conditions; a process whereby wider social forces shaping health opportunity and inequality are internalized over time by individuals. Evidence exploring health inequalities shows links between the environments people occupy and perceptions of stress, autonomy and selfefficacy, which in turn shape the self-regulation of risk behaviour [18, 19] . Some characterize this process as a kind of oppression illness in its effects among the socially excluded, including populations vulnerable to HIV [20] . In short, environments are regulators of hope and hope shapes risk decisions.
Two examples show how socioeconomic environment regulates risk taking and future discounting. In the first, excess deaths in the Chicago heat wave of 1995 were associated with decisions by older, chronically sick and immobile people to not purchase air conditioning equipment, while at the same time fearing opening their windows to gain adequate ventilation [21] . In the second, the United States obesity epidemic is shown to be closely related to processes of de-urbanization and de-industrialization [22] [23] [24] . Those studies illustrate the influence of the social environment in mediating health behaviour, privileging the accommodation of immediate risk over investing in health considerations for the future. Just as research shows links between social environments conducive to stress or uncertainty and health inequality [17] [18] [19] , HIV prevention research needs to investigate links between the environment, hope and the capacity for risk reduction.
Hope and HIV treatment
An international HIV treatment revolution, with a goal of near universal access by 2010, aims to help unlock many low-income countries, particularly those in sub-Saharan Africa, from a cycle of vulnerability in which HIV epidemics interact with poverty and other forms of inequality [25, 26] . Consistent access to ART creates an opportunity to curtail morbidity by reducing HIV to a manageable chronic illness, as well as increasing the capacity of individuals living with HIV/AIDS and their carers to maintain their livelihoods and economic productivity. In low-income settings, HIV treatment offers the possibility of reducing short-term survival decisions, which jeopardize long-term survival, encouraging investment in the future, with the result of mitigating against household dissolution and the intensification of poverty. The provision of ART may be an important component in HIV prevention through influencing the degree of hope associated with HIV diagnosis and the future [27] .
The relative success of the scale-up of global HIV treatment has generated a great deal of hope [28] . The World AIDS Conference of 1996 was themed 'One World, One Hope' to signify the advent of ART. Although we have recently been reminded that some African delegates displayed banners reading 'One World, No Hope' to signify major inequalities in treatment access in low-income countries [26] , the end of 2006 saw great strides towards global access to free HIV treatment. More than two million individuals in low and middle-income countries are now being treated with ART [29] . In many parts of the world, however, access to ART remains uneven and scarce [30] . Structural constraints on HIV treatment access and delivery produce fallout from this optimistic discourse of hope, which is absorbed by individuals delivering, receiving and waiting for treatment. Such fallout is likely to shape individuals' perceptions of their futures with ART. The importance of mental healthcare in ART delivery has been recognized [31] , but understanding and responding to the adverse psychological and social consequences from fragile treatment delivery remains largely unaddressed.
The progress of HIV treatment rollout in low-income and transitional settings is hampered to varying extents by financial, organizational and physical obstacles [32] . There are reports of inconsistent treatment delivery from a breadth of regions [33] [34] [35] [36] . Although unsurprising given the enormity and contextual realities of the scale-up effort, little rigorous work has examined how individuals and communities navigate such uncertainty. For example, the environmental and bureaucratic constraints leading to the 'torpid pace' of the treatment rollout in South Africa has been said to have 'squandered hopes', resulting in a politics of rationing by treatment providers and dashed treatment expectations for individuals living with HIV [30] . Those with established treatment access remain vulnerable to the fragility of donor-dependent treatment delivery [37] . A temporary suspension of Global Fund support to Uganda in 2005 introduced serious uncertainties about the continuity of HIV treatment. This was amplified locally through a combination of rumour and anxiety. Concerns about the sustainability of HIV treatment supplies in Uganda remain, with occasional local press reports that antiretroviral drugs have 'run out' [38] . Improved understanding of the fallout experienced from the disjuncture of expectation and promise on the one hand, and experience and uncertainty on the other, is practically and ethically necessary as an aid to developing treatment support interventions for individuals as well as cautionary lessons in relation to raised expectations, hope and disappointment.
Understanding hope in HIV treatment
Much can be gained from researching narratives of hope and uncertainty related to HIV treatment. Sociological research in rich countries found that ART altered conceptualizations of HIV as well as of risk, security and the future. These shifts have been interpreted as 'risk productive' as well as 'risk reductive'. For example, the physical renewal associated with HIV treatments has enabled a renegotiation of social identities, roles, relationships and temporal orientations [39, 40] ; whereas the recession of imminent death may bring new uncertainties in relation to perceptions of life expectancy, identity as long-term survivors, and treatment side effects, adherence and treatment resistance [41] [42] [43] .
The extent to which HIV treatment is experienced by individuals living with HIV as a solution to risk, as the promise of hope, or as risk potential varies widely given differences in treatment context. Although hope is defined broadly as a positive expectation of the future [44, 45] , the meanings of time horizons are place specific [46] . Social science research in rich world settings has examined the role hope plays in patients' management of chronic illness, as well as HIV/AIDS [44, [47] [48] [49] ], yet these studies may be inappropriate to environments in which acute vulnerability to illness is not experienced as a major 'biographical disruption' [50, 51] , and in which risk and insecurity are dominant characteristics of existence. The behaviour outcomes informed by HIV diagnosis, the opportunity of treatment access, and individuals' perceptions of future may be quite different in settings characterized by intense poverty, daily struggle, high HIV prevalence and fragile HIV treatment delivery [26] .
Alongside the 'risk reducing' promise of HIV treatment related to health improvement and the renewal of productivity, it is important to explore the possibility of 'risk producing' consequences of treatment opportunity. For example, the fallout from the experience of fragile delivery has implications for patients' physiological and psychological wellbeing, as well as for future illness management, adherence and viral resistance [52] . It is unknown, for example, how the management of HIVas a chronic condition in low-income settings will be balanced alongside 'new' risks such as viral resistance and treatment side effects [39, 41, 43] and 'pre-existing' risks, for example access to basic life resources such as nutrition, finance and relationship security as well as risky behaviour and reproductive life choices associated with treatment optimism [53, 54] .
We suggest that an environment that fosters hope in access to ART and in the delivery and outcome of ART is a critical factor mediating risk and life decisions. As illustrated by Fig. 2 , we hypothesize that environments characterized by fragile HIV treatment systems foster the loss of hope, in turn linking with a weakened capacity for investing in the future through HIV treatment engagement. Although environments offering stable and secure HIV treatment are not without risk or uncertainty (as we have noted above), they may serve to maintain hope, and thus also a long-term perspective realized through HIV treatment engagement. Figure 2 highlights the need for interventions that create environments conducive to securing hope. We are arguing that long-term successful HIV prevention and treatment requires environments protective of hope, and which promote as well as sustain a positive expectation of, and investment in, the future. This means it is crucially important to protect against the creation of an illusion of hope through global promises that can not be met locally. Within these boundaries, it is equally important to invest in social and structural interventions that are protective of hope. These include: improved treatment system delivery; systematic reviews of treatment systems before scaling up; psychosocial support for staff delivering ART and individuals receiving or awaiting treatment; increased attention to treatment literacy and communication of treatment expectations, including in relation to rationing; contingency plans and emergency treatment funds in situations of treatment disruption or shortages of supply; enhancement of community advocacy and links to community support organizations; and linked nutritional and healthcare support [26, 30, 55, 56] .
Importantly, Fig. 2 whose parents have died of AIDS as a result of the ineffective delivery of, and weakened capacity to adhere to HIV treatment is situated in a higher risk environment to contract HIV than if she or he had been parented into early adulthood [57] . Hope, or more specifically, environments in which hope is secured and sustained, protects against this generational cycle of HIV risk production.
The need for an emic perspective
Despite the pertinence of delivery in shaping the social impact of ART, there is a marked absence of research capturing the lived experience of HIV treatment opportunity in the context of global treatment scaleup. This is especially the case in low-income settings. This reflects a lack of qualitative or ethnographic research capacity, as well as a lack of emphasis on research that is critically reflexive of internationally endorsed interventions which hold so much promise.
As with HIV prevention, the primary focus of research on target reaching and treatment adherence places the burden of responsibility on the individual [58] . The capacity of the treatment system to adhere to its delivery commitments has barely been researched, and few studies have explored the effects of how the treatment promise and insecurity of its provision is experienced [56, 59] . We therefore emphasize the need for studies of the social impact of ART to capture the perspectives of those delivering, receiving and hoping to access treatment.
We believe that the complex and pervasive impact of fragile treatment delivery on the everyday lived experience of individuals living with HIV/AIDS within this current period of treatment scale-up is best captured by qualitative methods, and ideally through treatment ethnography. Ethnography is a distinct form of qualitative research, emphasizing holism (understanding the social environment of lived experience), immersion (understanding social relationships through engagement), and triangulation (comparing multiple accounts and forms of data). Capturing the narratives of hope, risk and treatment experience among those delivering, receiving and eligible to receive ART is a fundamental step toward informing treatment delivery and generating an empirically informed ethics of treatment provision [47] [48] [49] .
Understanding emic perspectives of hope, related to HIV treatment through ethnography, leads to better grounded survey and evaluation studies of treatment outcome and adherence, as well as to hypotheses linking hope and the risk environment that are potentially testable through quantitative designs. Taken together, there is a need for multi-methods research capable of understanding how treatment experience, expectation and outcome are linked to environment.
A case example in HIV treatment uncertainty As one HIV-positive individual reports, the weak HIV treatment delivery system affects the psychological state of people: 'They fall into depression. They feel they have no future'. Such uncertainty and anxiety is exacerbated by an awareness of dependency upon fragile and unpredictable systems of treatment and expertise ('We are dependent on others'; 'We cannot provide medicines for ourselves'; 'If you are lucky someone remembers to call you and tell you to run to the clinic'). We have found that the HIV treatment experience feeds a cycle of risk production, with the consequence that some patients fluctuate between hope and hopelessness, between managing their HIV as a chronic condition and as a terminal illness: 'We started to be desperate at that time because somebody who has been on treatment for a few years, suddenly they found hope again and when you don't have treatment everything is lost.' (HIV-positive woman, aged 41 years); 'If the purpose of all this is to improve quality of life, for these people stress is the cause of bringing this quality a step lower. . . Alright, we can't beat it, we can't cure it, but in a way at least allow people, give them some hope, if that's what we're talking about.' (HIV-positive woman, aged 35 years).
HIV treatment providers also need to find ways of coping with the anxieties of failed treatment expectation while recognizing that it is individuals living with HIV who absorb most of the fallout of lost treatment opportunity ['They (patients) lose control. They are anxious about it. Their fears about the future rise. It's very difficult to think about how they manage their lives']. We found that some participants' experience of treatment shortages have undermined their trust in the benefits of ART ['They don't believe in this therapy after that (treatment shortage)']. Some people living with HIV decided to stop or not begin ART because they perceived it to be 'more risks than things to gain'.
Participants attributed HIV treatment interruptions partly to the socioeconomic conditions of their environment. They perceived this to restrict their expectation for secure and continuous delivery in the future. Some rationed their hope as a way to manage the risks associated with failed treatment opportunities ('How can I be disappointed if it wasn't something I expected?'). Crucially, this environment in which individuals perceived there to be limited hope also acted to undermine motivation to participate in community advocacy to improve treatment opportunities.
This brief case study of the experience of treatment delivery illustrates the role of hope in mediating risk and outcome. It also demonstrates the negative fallout from an intervention that fails to deliver on its promises. Ethnographic studies of the lived experience of shortages of treatment supply and 'treatment rationing' through enforced regime change and 'drug holidays' in Serbia and Montenegro [33] are likely to be as useful as ethnographic studies investigating slow treatment rollout to eligible individuals in South Africa [30] or 'capped' treatment access in Togo [37] .
Conclusion
Social environments are regulators of risk and hope. One feature of risk environments is that they do not engender hope or encourage long-term planning or decision making. The absence of hope and lack of investment in the future, discounting of the future, may foster vulnerability to health harm by weakening self and community regulation of risks, including in relation to HIV. Although global initiatives to scale-up access to HIV treatment offer a discourse of hope, treatment inconsistency and uncertainty are likely to be common characteristics of long-term free access to treatment in many settings [32] . Hope generated by discourses of HIV treatment promise inversely introduces fallout in which the fragility of dependency and fear of disappointment can reproduce a pervasive sense of risk or insecurity for individuals living with HIV. Treatment without appropriate psychological and social support exposes individuals to the full blast of health system weaknesses.
It is important to reflect upon the potential social consequences, some unforeseen and adverse, of HIV behavioural and medical intervention. First, we must recognize that without hope behaviour is harder to change and long-term treatment harder to achieve. Second, we need to appreciate how hope relates to structural conditions such as relative social position, political stability, gender inequality and system operations.
Third, we need to develop prevention and treatment interventions to prevent as well as reduce the human costs of the potential fallout resulting from the loss of hope, including the provision of social support and contingency or emergency treatment in times of disruption. Finally, we need a longer term vision in developing and researching interventions that enable environments that can shape and sustain hope through HIV prevention and HIV treatment engagement. Hope is an under-researched concept in relation to HIV prevention and treatment. It is a variable that focuses on the condenser effect of socioeconomic environments onto individual behaviours, and is thus a core feature of the degree to which risk environments enable or disenable sustained consistent HIV treatment and behaviour change.
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